초록 ▼

A novel method for the prevention of infectious diarrhea or diarrhea caused by antibiotic therapy is disclosed. The method comprises the steps of 1) mixing a powder comprising viable cultures of the probiotic organisms Lactobacillus reuteri, Lactobacillus acidophilus and Bifidobacieriurn infantis wi

A novel method for the prevention of infectious diarrhea or diarrhea caused by antibiotic therapy is disclosed. The method comprises the steps of 1) mixing a powder comprising viable cultures of the probiotic organisms Lactobacillus reuteri, Lactobacillus acidophilus and Bifidobacieriurn infantis with a liquid; and 2) enterally administering the mixture to a mammal or a human. In a preferred embodiment at least 10.sup.6 CFU (colony forming units) of each probiotic organism is consumed per day. The invention also relates to pills or capsules containing the probiotic system (Lactobacillus reuteri, Lactobacillus acidophilus and Bifidobacterium infantis) in a freeze dried or lyophilized form. The invention also relates to a novel powdered nutritional formula for the prevention of diarrhea that comprises protein, fat, carbohydrates and the microorganisms Lactobacillus reuteri, Lactobacillus acidophilis and Bifidobacterium infantis. In a preferred embodiment the powdered nutritional formula is a nutritionally complete infant formula. A large clinical study has shown that the probiotic system according to the invention when provided in a non-fermented form is efficacious in the prevention of diarrhea. Also disclosed is a method for manufacturing the formula of the invention.

대표청구항 ▼

[ What is claimed is:] [1.] A method for reducing the incidence of infectious diarrhea or diarrhea caused by antibiotic therapy in a human, said method comprising the steps of 1) mixing of a powder containing viable Lactobacillus reuteri, Lactobacillus acidophilus and Bifidobacterium infantis with a

[ What is claimed is:] [1.] A method for reducing the incidence of infectious diarrhea or diarrhea caused by antibiotic therapy in a human, said method comprising the steps of 1) mixing of a powder containing viable Lactobacillus reuteri, Lactobacillus acidophilus and Bifidobacterium infantis with a liquid and 2) enterally administering an effective amount of said liquid mixture to said human prior to the formation of fermentation by-products.